my knowledge, this is the first time active thrombin generation was quantified in an in-vitro system that imitates the in vivo interaction of LPS or glucans with blood.
MATERIALS AND METHODS

Determination of Plasmatic Lipopolysaccharides
Plasmatic LPS was determined by a modified Limulus-assay: 10 µL plasma or standard were incubated with 10 µL 60 mM chloramine-T (Sigma, Deisenhofen, Germany) in phosphatebuffered saline (PBS, Sigma) for 10 minutes (37°C) to inactivate anti-Limulus factors of plasma. Ten microliters 230 mM methionine (Sigma) were added. After 3 minutes (room temperature [RT]) 30 µL Limulus-reagent (Pyrochrome; CAPE COD, Falmouth, USA; reconstituted in 3.2 mL 0.2 M Tris, pH 8) were added and the increase in absorbance at 405 nm (RT) was determined (hyperbolic rate assay, 1 ng/mL LPS reactivity in normal plasma is detected at 45 to 60 minutes RT).
Incubation of Normal Blood with Endotoxin
Nine milliliters of blood of healthy donors (0.8 ± 0.2 ng/mL plasmatic LPS [MV±1SD]) was drawn into monovettes containing 1 mL 106 mM sodium citrate (Sarstedt, Nümbrecht, Germany). Five hundred-microliter aliquots of fresh blood were incubated with 25 µL freshly prepared 0 to 16800 ng/mL LPS in physiologic NaCl → blood concentration up to 800 ng/mL LPS (Escherichia coli 0111:B4; purified by gel filtration; product L 3012; Sigma, Deisenhofen, Germany; stabilized with 5% human albumin, Kabi Stockholm, Sweden). The LPS reactivities in septic patients can increase 100 to 1000-fold compared to those in healthy individuals (8, 9) . Therefore, LPS was added in concentrations up to 800 ng/mL. Fresh blood was also incubated with zymosan A (ZyA; Sigma) at blood concentrations up to 80 µg/mL. The cups were incubated for 30 minutes at RT or as a control for 10 minutes at 37°C (endotoxin exposure time [EET] ).
Coagulation Reaction Time
The cups were centrifuged at 11500 U/mL. Four times 30 µL plasma of each cup were incubated with 30 µL 25 mM CaCl 2 for 0, 5, 8, 12 minutes (37°C) coagulation reaction time (CRT) in a microtiter plate (U-wells; NUNC, Wiesbaden, Germany). Twenty microliters 2.47 M arginine, pH 8.6 were added (assay concentration, 618 mM; Sigma: 2.61 g arginine free base [MW=174.2] +9.01 g arginine-HCl [MW=210.7] +15 mL H 2 O + 400 µL 37% HCl results in 23.4 mL 2.47 M arginine, pH 8.6). Zerominute CRT= first addition of arginine, then addition of Ca 2+ ; more than 200 mM arginine stops coagulation (10) . The absorbance of the plate was measured at 405 nm using a microtiter plate reader (Milenia, DPC Biermann, Los Angeles, USA).
Thrombin Determination
Fifty microliters 0.9 mM chromogenic thrombin substrate HD-CHG-Ala-Arg-pNA (Pentapharm, Basel, Switzerland) in 2.3 M arginine, pH 8.6 (CS-IIa; final conc.: 0.35 mM CS and 1.26 M arginine) were pipetted with an Eppendorf-multipette into the plate and the absorption at 405 nm was determined immediately (BASE-value) and after 6, 60, and 300 minutes (RT). Fresh thrombin standards were 1 IU/mL (→ about 20 mA/min RT) and 10 mIU/mL bovine thrombin (DadeBehring, Marburg, Germany) in 7% human albumin that replaced the plasma. The obtained ∆A values were transformed into international units thrombin per milliliter according to the activity measured for the thrombin standards (11) . The determinations were performed in duplicate. The intra-assay CV values were 5% or less.
Variation of Coagulation Reaction Time Blood exposed to Lipopolysaccharides
Freshly drawn citrated blood of one healthy donor was supplemented with 0 ng/mL LPS, 0.4 ng/mL LPS, 4.9 ng/mL LPS, 60 ng/mL LPS, or 736 ng/mL LPS. After 70 minutes (37°C) EET, the blood was centrifuged and 30-µL samples of plasma were recalcified with 30 µL 25 mM CaCl 2 and incubated for 0 to 30 minutes (37°C). Twenty microliters 2.47 M arginine were added. Thrombin was detected by addition of 50 µL 0.9 mM HD-CHG-Ala-Arg-pNA in 2.3 M arginine and measurement of ∆A/min (RT).
Blood exposed to Zymosan A
Freshly drawn blood of one healthy donor was supplemented with 0 µg/mL ZyA, 0.05 µg/mL ZyA, 0.6 µg/mL ZyA, 7.4 µg/mL ZyA, or 90 µg/mL ZyA. After 70 minutes (37°C) EET, the blood was centrifuged and 30 µL samples of plasma were recalcified with 30 µL 25 mM CaCl 2 and incubated for 0 to 30 minutes (37°C). Twenty microliters 2.47 M arginine were added. Thrombin was detected by addition of 50 µL 0.9 mM HD-CHG-Ala-Arg-pNA in 2.3 M arginine and measurement of ∆A/min (RT).
Variation of Endotoxin Exposure Time
One thousand eight hundred eighty microliters freshly drawn citrated blood of one healthy donor was mixed with 133 µL 0, 100, 1000 ng/mL LPS or 100 µg/mL ZyA, resulting in final added concentrations of 0 ng/mL LPS, 6.6 ng/mL LPS, 66 ng/mL LPS, or 6.6 µg/mL ZyA. Two hundred-microliter aliquots were endotoxin exposed for 0 to 80 minutes at RT or 37°C. After centrifugation, 30 µL samples were incubated with 30 µL 25 mM CaCl 2 for 10 minutes (37°C). Ten microliters 2.47 M arginine, pH 8.6, and 40 µL 0.9 mM CS in 2.2 M arginine were added and ∆A at RT was determined.
Inhibition of Coagulation Activation by Arginine
Four hundred microliters freshly drawn citrated blood of one healthy donor were incubated with 44 µL physiologic NaCl (0 ng/mL LPS supplemented) or 1000 ng/mL LPS in NaCl (100 ng/mL LPS supplemented) and 44 µL 0 to 100 mM arginine (Braun, Melsungen, Germany). After 10 minutes (37°C), the blood samples were centrifuged and 30 µL plasma were incubated in duplicate with 10 µL 75 mM CaCl 2 in 4% human albumin for 10 minutes at 37°C or 15 minutes at 37°C. Ten microliters 2.47 arginine were added and the basal turbidity of the plasma before CS addition after 10 minutes (37°C) EET and 15 minutes (37°C) CRT was determined. Forty microliters 0.9 mM CS-IIa were added and ∆A was determined.
Citrated blood of healthy donors was supplemented in duplicate with 0 or 15 mM final arginine. After 90 minutes (RT) EET, the blood samples were centrifuged and 4 × 30 µL plasma were pipetted into a microtiter plate to measure thrombin generation after recalcification.
Citrated plasma from blood samples preincubated (30 minutes RT) with 0 ng/mL or 100 ng/mL supplemented LPS without arginine were now supplemented with arginine, pipetting the plasma samples into a microtiter plate prefilled with 5 µL 0 to 500 mM arginine (Braun). Ten microliters 75 mM CaCl 2 were added to both plates and the plates were incubated for 10 minutes (37°C ; water bath). Twenty microliters 2.47 M arginine, pH 8.6, were added. The absorption at 405 nm was determined. Fifty microliters HD-CHGAla-Arg-pNA (0.9 mM in 2.3 M arginine) were added and ∆A at 405 nm was determined. The obtained values were calibrated against a 1 IU/mL thrombin standard.
Monocyte and Platelet Count after Endotoxin Exposure to Blood
LPS or 100-fold ZyA were added to citrated blood 0 to 74 ng/mL (final conc.). After 60 minutes (37°C), the blood was analyzed for monocytes or platelets in an automatic hematologic analyzer (Sysmex, Hamburg, Germany).
Two hundred fifty microliters 0 ng/mL or 1000 ng/mL LPS in physiologic NaCl (→ blood with 0 ng/mL or 100 ng/mL LPS supplemented) were incubated with 2250 µL pooled unselected samples (8 hours old, RT) of citrated blood (n=10) or EDTA-blood ( n=25) for 0 to 60 minutes (37°C) and automatically analyzed for monocytes, neutrophil granulocytes, and platelets.
sCD14 Antigen in Plasma of Blood Exposed to Lipopolysaccharide
Plasma samples of blood exposed to LPS (frozen/thawed) were analyzed for soluble sCD14 antigen by ELISA (IBL, Hamburg, Germany).
TF Antigen in Plasma of Blood Exposed to Lipopolysaccharide
Plasma samples of blood exposed to ZyA (frozen/thawed) were analyzed for TF antigen by ELISA, prolonging the final incubation from 20 to 60 minutes (RT) (Imubind; American Diagnostics, Stamford, USA). Pooled normal EDTA-plasma has 140 pg/mL TF.
Whole Blood Recalcification That Was Supplemented with Lipopolysaccharide
One hundred twenty-five microliters freshly drawn citrated blood were supplemented with 5 µL 0 ng/mL LPS, 270 ng/mL LPS (→10 ng/mL final), or 2700 ng/mL LPS (in 0.5% human albumin → 100 ng/mL final) and 5 µL 350 mM CaCl 2 . After 0 to 16 minutes (37°C), 25 µL 1470 mM arginine, pH 8.7, were added. The samples were centrifuged and 25 µL plasma were incubated with 25 µL 0.9 mM CS-IIa in 2.3 M arginine.
Recalcification of LipopolysaccharideReacted Blood
One hundred twenty-five microliters fresh citrated blood of four healthy donors were supplemented with 2 µL 0 ng/mL, 1290 ng/mL (20 ng/mL final), or 12,900 ng/mL (200 ng/mL final) in 0.5% human albumin for 30 minutes (RT). Two microliters 875 mM CaCl 2 were added. After 0 to 60 minutes (RT), 25 µL 1631 mM arginine, pH 8.7, were added. The samples were centrifuged and 50 µL plasma were incubated with 50 µL 0.77 mM CS-IIa (Pentapharm, Basel, Switzerland; 10 µmoL dissolved in 1 mL H 2 O, then addition of 12 mL 2.47 M arginine, pH 8.6) in 2.3 M arginine (Sigma). Change in absorbance at 405 nm was determined and calibrated against a 1 IU/mL thrombin standard (DadeBehring, Marburg, Germany).
Inhibition of Contact Phase-Activated Hemostasis by Arginine
Twenty microliters fresh pooled normal citrated plasma with 120 pg/mL TF were incubated with 2 µL 0 to 1000 mM arginine, pH 7.4, 2 µL 0% , 0.1%, 1%, and 10% Pathromtin SL (DadeBehring) in 0.9% NaCl, giving final PSL concentration of: 0%, 0.008%, 0.083%, and 0.83% or salmon DNA in final concentration of 0 µg/mL, 0.03 µg/mL, 0.3 µg/mL, 3 µg/mL. The coagulation reaction was started by addition of 2 µL 250 mM CaCl 2 . After 5 minutes and 10 minutes CRT, the reaction was stopped by arginine and thrombin was detected as described previously.
Thrombin Generation by Tissue Factor in Recalcified Pooled Normal Plasma
Fifty microliters pooled normal citrated plasma (< 6 hours RT old, unfrozen) were incubated with 5 µL 0% to 100% Thromborel-S (100% = 160 ng/mL TF; DadeBehring) in physiologic NaCl and 5 µL 250 mM CaCl 2 for 0 to 20 minutes (37°C). Fifty microliters 2.47 M arginine, pH 8.6 were added and the well absorbance at 405 nm was determined. Then 50 µL 0.77 mM CS-IIa in 2.3 M Arg, pH 8.6 were added and ∆A/min (RT) was determined. The final TF concentrations were 100 pg/mL, 113 pg/mL, 233 pg/mL, 1433 pg/mL, and 13433 pg/mL.
Thrombin Generation by SiO 2 in Recalcified Pooled Normal Plasma
Fifty microliters pooled normal citrated plasma (< 6 hours RT old, unfrozen) were incubated with 5 µL 0% to 100% Pathromtin SL in physiologic NaCl and 5 µL 250 mM CaCl 2 for 0 to 20 minutes (37°C). Fifty microliters 2.47 M arginine, pH 8.6 were added and the well absorbance at 405 nm was determined. Then 50 µL 0.77 mM CS-IIa in 2.3 M Arg, pH 8.6 were added and ∆A/min (RT) was determined. The final Pathromtin SL concentrations were 0%, 0.083%, 0.83%, and 8.3%.
Thrombin Generation by DNA in Recalcified Pooled Normal Plasma
Fifty microliters pooled normal citrated plasma (< 6 hours RT old, unfrozen) were incubated with 5 µL 0 to 3.6 mg/mL salmon DNA (Sigma, dissolved under heating at 95°C for 10 min) in physiologic NaCl and 5 µL 250 mM CaCl 2 for 0 to 20 minutes (37°C). Fifty microliters 2.47 M arginine, pH 8.6 were added and the well absorbance at 405 nm was determined. Then 50 µL 0.77 mM CS-IIa in 2.3 M Arg, pH 8.6 were added and ∆A/min (RT) was determined.
Thrombin Generation by Destroyed Buffy Coat in Recalcified Pooled Normal Plasma
Fifty microliters pooled normal citrated plasma (< 6 hours RT old, unfrozen) were incubated with 5 µL 0% to 100% destroyed buffy coat (35,700 leukocytes/µL, 400,000 erythrocytes/µL, 26,900 neutrophils/µL, 6250 lymphocytes/µL, 1178 monocytes/µL, 643 eosinophils/µL, 714 basophils/µL, 491,000 platelets/µL; pooled from n = 18 unselected citrated blood samples and diluted five-fold with physiologic NaCl; frozen/ thawed) in physiologic NaCl and 5 µL 250 mM CaCl 2 for 0 to 20 minutes (37°C). Fifty microliters 2.47 M arginine, pH 8.6 were added and the absorbance of the well content at 405 nm was determined. Then 50 µL 0.77 mM CS-IIa in 2.3 M Arg, pH 8.6 were added and ∆A/min (RT) was determined. The final destroyed buffy coat concentrations were 0, 30, 298, and 2975 lysed cells/µL.
RESULTS
LPS exposure to whole citrated blood increases the thrombin generation in the respective recalcified plasma: 12-minute coagulation reaction time (CRT) gives rise to about 200 mIU/mL thrombin in blood exposed to 200 ng/mL LPS (Fig. 1D) ; 8-minute CRT results in about 100 mIU/mL thrombin in blood exposed to 200 ng/mL LPS (Fig. 1C) ; without LPS addition, the thrombin generation within 12 or 8-minute CRT is about tenfold lower. At a CRT of 5 minutes, markedly less thrombin is generated (Fig. 1B) . The thrombin detectable at a CRT of 0 minutes is constant over the whole range of added LPS; i.e., in the EET no thrombin is generated, the only thrombin detectable is the normal plasmatic concentration of thrombin (Fig. 1A, 1E) ; the same holds true for the ZyA-reacted blood ( Fig. 2A,  2E) . ZyA is approximately 100-fold less effective compared to LPS (Fig. 2B-D) .
Fig . 3A , B shows the relation between the CRT and the generated thrombin: after 70 minutes EET (37°C), the optimal CRT is about 10 to 20 minutes (37°C), longer CRT results into increased unspecific activation of coagulation. 
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Fig . 4A , B demonstrates the relation between the EET and the generated thrombin-with respect to unspecifities, room temperature is better than 37°C. Therefore, RT was chosen as the ideal EET incubation temperature and 30 minutes was chosen as the ideal incubation time.
Blood arginine at about 7 mM decreases the LPS-induced thrombin generation or the generated plasmatic turbidity (fibrinogen→fibrin conversion by thrombin) by 50% (Fig. 5A-C) . Plasmatic arginine at 10 to 15 mM decreases the thrombin generation in LPS-supplemented or un -FIG. 4 . Thrombin in recalcified plasma after different LPS/blood reaction times. Freshly drawn citrated blood of one healthy donor was exposed to added 0 ng/mL LPS (O), 6.6 ng/mL LPS (I), 66 ng/mL LPS (G), or 6.6 µg/mL ZyA (*) for 0 to 80 minutes at RT (A) or 37°C (B). After centrifugation 30-µL samples were incubated with 30 µL 25 mM CaCl 2 for 10 minutes (37°C). Ten microliters 2.47 M arginine, pH 8.6 and 40 µL 0.9 mM CS in 2.2 M arginine were added and ∆A at RT was determined.
4A 4B FIG. 5.
Inhibition of thrombin generation in plasma of endotoxin-reacted blood by arginine. Freshly drawn citrated blood of one healthy donor was incubated with added 0 ng/mL (O) or 90 ng/mL LPS and 0 to 100 mM arginine. After 10 minutes (37°C), the blood samples were centrifuged and 30 µL plasma were incubated with 10 µL 75 mM CaCl 2 in 4% human albumin for 10 minutes at 37°C (A) or 15 minutes at 37°C (B). Ten microliters 2.47 arginine and 40 µL 0.9 mM CS-IIa were added and ∆A was determined. C: Basal turbidity of the plasma before CS addition after 10 minutes (37°C) EET and 15 minutes (37°C) CRT. Citrated blood of two healthy donors was supplemented with 0 ng/mL LPS (O) and 100 ng/mL LPS (G). After 90 minutes (RT) the samples were centrifuged. The plasmas were supplemented with arginine, recalcified, and assayed for plasmatic thrombin (CRT = 10 minutes 37°C). D: donor 1; E: donor 2. F: Thrombin generation in blood samples of three healthy donors that were incubated with 0 mM or 15 mM arginine (final blood concentration); donor 1 = black columns, donor 2 = grey columns, donor 3 = white columns.
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supplemented blood by 50% (=IC50) (Fig. 5D,  E) . Fifteen millimolar blood arginine strongly decreases thrombin generation in normal blood incubated for 90 minutes (RT) (Fig. 5F) .
LPS exposure to citrated or EDTA blood (100 ng/mL; 60 minutes 37°C) results in an approximate 30% loss in countable monocytes and platelets (Fig. 6A, B) .
There appeared to be no change in sCD14 in LPS-exposed blood without or with addition of arginine (Fig. 7A, C) . TF-antigen did not increase upon LPS exposure to blood, instead there was a decrease in TF-antigen at LPS concentration of 100 ng/mL or greater (Fig. 7B, D) .
Whole citrated blood with common EET and CRT (37°C) (Fig. 8) or whole citrated blood with
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FIG. 6. Monocytes and platelets decline upon endotoxin exposure to blood. To citrated blood 0 to 74 ng/mL (final concentration) LPS (circles) or 100-fold ZyA (squares) were added. After 60 minutes (37°C), the blood was analyzed for monocytes (filled symbols) or platelets (open symbols) in an automatic hematologic analyzer. For ZyA the x-values have to be multiplied by 100; for platelets, the yvalues have to be multiplied by 1,000 (A). Pooled unselected samples of citrated blood (____) or EDTA-blood (----) was exposed to added 0 ng/mL or 100 ng/mL LPS for 0 to 60 minutes (37°C) and automatically analyzed for monocytes (G), neutrophil granulocytes (I; y-values × 10), and platelets (∆; y-values × 1,000) (B). separated EET (RT) and CRT (RT) (Fig. 9A, B) should not be used to study thrombin generation, because in whole blood the generated unspecific hemostasis activation is much higher than in platelet-poor plasma. Arginine inhibits the contact phase of hemostasis induced by SiO 2 or DNA with an inhibitory concentration 50% of about 20 mM (Fig. 10A, B) . The TF pathway of hemostasis can be measured precisely with the present technique: TF acts more rapidly (Fig. 11A, B) than the contact phase activators SiO 2 (Fig. 12A,  B) or DNA (Fig. 13A, B) . Interestingly, 3 µg/mL DNA acts stronger than 300 µg/mL, possibly due to folding of the DNA, whose polynegative regions get more accessible to the contact factors of hemostasis.
Lysed buffy coat activates hemostasis similarly as the contact activators (Fig. 14A, B) : about 3000 lysed cells per microliter reaction mixture strongly activate hemostasis comparable to 0.1% Pathromtin SL or 3 µg/mL DNA. Even 300 lysed cells/µL activate hemostasis about fivefold.
DISCUSSION
The human organism is very susceptible to endotoxin releasing microorganisms. Endotoxin is an old expression for lipopolysaccharides (LPS) from gram-negative bacteria (12) , but also certain cell wall components of fungi-the glucans-can act as pyrogenics and therefore glucans might also be considered a subclass of endotoxin; also fungi can cause DIC (13) .
The exact pathogenesis of the endotoxin/ monocyte/thrombin pathway is up to now unknown. What are the known biochemical actions of LPS or zymosan activate the phospholipases A 2 , C, and D (PLA 2 , PLC, PLD) and intracellular protein kinases (e.g., PKC) (14-17); monocyte membranes are rich in phospholipases and in releasable arachidonic acid, the precursor substance for prostaglandin or leukotriene synthesis; monocyte activation correlates with changes in the composition of membrane phospholipids (18) . Via PLA 2 activation, LPS induce accumulation of unsaturated lipids in monocytes, resulting in an increase in monocyte membrane fluidity (19) . Thus, LPS can activate the arachidonic acid cascade (20, 21) . Thrombin generation by TF in recalcified pooled normal plasma. Fifty microliters pooled normal citrated plasma (< 6 hours RT old, unfrozen) were incubated with 5 µL 0% to 100% Thromborel-S (100% = 160 ng/mL TF) in physiologic NaCl and 5 µL 250 mM CaCl 2 for 0 to 20 minutes (37°C). Fifty microliters 2.47 M arginine, pH 8.6 were added and the well absorbance at 405 nm was determined (B). Then 50 µL 0.77 mM CS-IIa in 2.3 M Arg, pH 8.6 were added and ∆A/min (RT) was determined (A). The final TF concentrations were 100 pg/mL (O), 113 pg/mL (∆), 233 pg/mL (L), 1433 pg/mL (I), 13433 pg/mL (G).
11A 11B
Furthermore, LPS induce expression of PLA 2 in macrophages (22, 23) and seem to activate oxygen radical production in monocytes (24) . PLA 2 releases arachidonic acid that stimulates NADPH oxidase and membrane redistribution; PLC releases inositol-3,4,5-triphosphate and diacylglycerol (DAG) that stimulate NADPH oxidase and PKC (25) . PLA 2 is activated by DAG (26).
Of importance is that PLA 2 can be inactive (in unstimulated cells) or active (in stimulated cells). PLA 2 trapped in a subcellular compartment away from the membrane (e.g., the cytosolic PLA 2 =cPLA 2 ) or membranous PLA 2 with a hidden active center is inactive. PLA 2 can be stimulated by a range of substances (27) (28) (29) (30) . The cytosolic PLA 2 is activated by Ca 2+ -dependent translocation; PLA 2 must first anchor to the mem- 
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brane to gain access to its substrate; the His 48 residue of the catalytic site together with an Asp 99 residue are essential for catalysis (16) . Phosphorylation modifies PLA 2 activity (16, 31, 32) . LPS activates inactive PLA 2 (33) . LPS induces matrix metalloproteinases (34) . Annexin 1 (a phospholipids-and calcium-binding protein) stabilizes the inactive form of PLA 2 (35) .
One critical step in the pathologic action of LPS/monocytes on hemostasis seems to be this activation of phospholipases: PLA 2 inhibitors block the LPS-induced hypercoagulation in monocytes (36) . PLA 2 and PLC can hydrolyze membranes, disrupting them, resulting in cell leakage or cell death (16, (37) (38) (39) . DAG destabilizes membrane bilayers (38) . 
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CD14 is considered a LPS receptor on monocytes (40) . Also CD11b/18 seems to interact with LPS (33) . CD14 is a glycosyl-phosphatidylinositol-anchored surface glycoprotein and LPS acts on CD14 dependently and independently (direct interaction with the cell membrane or critical proteins of the cell membrane) (41, 42) . CD14 is downregulated on stimulated monocytes (43) . LPS induces CD14 and TF expression (44) . There was no increase in soluble CD14 in blood treated with endotoxin, indicating that the LPS action on blood cells might mainly be CD14 independent. There was no increase in plasmatic TF.
TF in DIC-patients is about 250 pg/mL (only 20% more) compared to about 200 pg/mL in non-DIC patients (45) . A lysed mononcyte has tenfold more thrombin-generating power than it would be deduced just from its TF content (46) . Although functional TF is entirely cell-surface expressed on LPS-stimulated monocytes, lysed cells show greater than fivefold factor Xa generation than intact cells (47) .
These findings indicate that either the TF is somehow encrypted in the living cell or TF is not the main pathway of coagulation activation by monocytes that are exposed to LPS.
The present data suggest that in LPS-blood pathophysiology it might be primarily the contact activation of coagulation. In septic shock, about 500-fold increased circulating levels of PLA 2 (100% of norm = 7.3 ± 2.6 ng/mL) or about 100 to 200-fold increased circulating PLA 2 activity were measured (16, 48) . Intravenous LPS increased the PLA 2 activity in blood of healthy individuals about tenfold (49) . PLA 2 receptor-deficient mice are resistant against endotoxic shock (50) .
The contact system of hemostasis is activated in septicemia (2, (51) (52) (53) . Within 1 hour after intravenous administration of purified LPS to healthy individuals, a severe monocytopenia and thrombinemia occurs (54) . The DNA of lysed monocytes or endothelial cells might activate the contact system of hemostasis: negatively charged substances including DNA or phospholipid vesicles (microparticles) could be relevant contact activators (55) . One nucleated cell has about 6.8 pg DNA = about 70 µg/mL plasma, if all blood leukocytes (5,000 cells / µL) are lysed; lysis of about 200 nucleated cells/µL results into 3 µg/mL free plasmatic DNA (Figs. 10, 13) (56) . Taken together, the complex interaction between cell fragments and hemostasis may cause PDIC in sepsis (2, 57) . Sepsis-PDIC might be considered a snake bite (16) .
In physiology, LPS activates PLA 2 or PLC, resulting in a change of the fluidity of the monocyte membrane, facilitating phagocytosis of the pathogen. In pathophysiology, too much LPS disorganizes the membranes. Membrane perturbation activates PLA 2 , and activated PLA 2 increases membrane perturbation. The cell membrane gets leaky, and the cell dies. DNA or PLA 2 activate the kallikrein pathway (58, 59) , and kallikrein enhances PLA 2 activity (60) . Primarily this contact activation and secondarily some increase in TF might generate a pathologic thrombin activity in septicaemia, that results in disseminated microthrombi (61) (62) (63) .
The present clinical-biochemical technique allows study of the important aspects of PDIC in a simple in vitro model.
